In clinical trials, patients using a 15 mg dose of Mounjaro for weight loss experienced a remarkable mean reduction of 20.9% in body weight over 72 weeks, compared to just 3.1% for those on placebo
H.ValentiL.HuY.-Y.et al (2024)
Overdosage and Emergency Management 16
Those are the types of clues Eli Lillys CEO, David Ricks, says his company will pursue next year, testing whether its GLP-1 drug, tirzepatide (called Mounjaro for diabetes treatment, and Zepbound for weight loss), could help with addiction to alcohol, nicotine, and other things we dont think about [as being] connected to weight. In comments he made in December, Ricks said the drugs might be anti-hedonicsmeaning they counteract our hedonistic pursuit of pleasure, be it from food, alcohol, or drugs
Aging 15 , 39043938 (2023)